New antagonists of LHRH. II. Inhibition and potentiation of LHRH by closely related analogues

S. Bajusz, V. J. Csernus, T. Janaky, L. Bokser, M. Fekete, Andrew V Schally

Research output: Contribution to journalArticle

126 Citations (Scopus)

Abstract

Modifications of the previously described LHRH antagonists, [Ac-D-Na1(2)1, D-Phe(4Cl)2, D-Trp3, D-Cit6, D-Ala10]LHRH and the corresponding D-Hci6 analogue, have been made to alter the hydrophobicity of the N-terminal acetyl-tripeptide portion. Substitution of D-Trp3 with the less hydrophobic D-Pa1(3) had only marginal effects on the antagonistic activities and receptor binding potencies of the D-Cit/D-Hci6 analogues, but it appeared to further improve the toxicity lowering effect of D-Cit/D-Hci6 substitution. Antagonists containing D-Pa1(3)3 and D-Cit/D-Hci6 residues, i.e. [Ac-D-Na1(2)1, D-Phe(4Cl)2, D-Pa1(3)3, D-Cit6, D-Ala10]LHRH (SB-75) and [Ac-D-Na1(2)1, D-Phe(4Cl)2, D-Pal(3)3, D-Hci6, D-Ala10]LHRH (SB-88), were completely free of the toxic effects, such as cyanosis and respiratory depression leading to death, which have been observed in rats with the D-Trp3, D-Arg6 antagonist and related antagonists. Replacement of the N-acetyl group with the hydrophilic carbamoyl group caused a slight decrease in antagonistic activities, particularly in vitro. Introduction of urethane type acyl group such as methoxycarbonyl (Moc) or t-butoxycarbonyl (Boc) led to analogues that showed LHRH-potentiating effect. The increase in potency induced by these analogues, e.g. [Moc-D-Na1(2)1, D-Phe(4Cl)2, D-Trp3, D-Cit6, D-Ala10]LHRH and [Boc-D-Phe1, D-Phe(4Cl)2, D-Pa1(3)3, D-Cit6, D-Ala10]LHRH, was 170-260% and persisted for more than 2 h when studied in a superfused rat pituitary system.

Original languageEnglish
Pages (from-to)425-435
Number of pages11
JournalInternational Journal of Peptide and Protein Research
Volume32
Issue number6
StatePublished - Dec 1 1988
Externally publishedYes

Fingerprint

Gonadotropin-Releasing Hormone
Rats
Substitution reactions
Cyanosis
Poisons
Urethane
Hydrophobicity
Hydrophobic and Hydrophilic Interactions
Respiratory Insufficiency
Toxicity

ASJC Scopus subject areas

  • Biochemistry

Cite this

New antagonists of LHRH. II. Inhibition and potentiation of LHRH by closely related analogues. / Bajusz, S.; Csernus, V. J.; Janaky, T.; Bokser, L.; Fekete, M.; Schally, Andrew V.

In: International Journal of Peptide and Protein Research, Vol. 32, No. 6, 01.12.1988, p. 425-435.

Research output: Contribution to journalArticle

Bajusz, S. ; Csernus, V. J. ; Janaky, T. ; Bokser, L. ; Fekete, M. ; Schally, Andrew V. / New antagonists of LHRH. II. Inhibition and potentiation of LHRH by closely related analogues. In: International Journal of Peptide and Protein Research. 1988 ; Vol. 32, No. 6. pp. 425-435.
@article{1b261cfc1e9e460085000199be1c0170,
title = "New antagonists of LHRH. II. Inhibition and potentiation of LHRH by closely related analogues",
abstract = "Modifications of the previously described LHRH antagonists, [Ac-D-Na1(2)1, D-Phe(4Cl)2, D-Trp3, D-Cit6, D-Ala10]LHRH and the corresponding D-Hci6 analogue, have been made to alter the hydrophobicity of the N-terminal acetyl-tripeptide portion. Substitution of D-Trp3 with the less hydrophobic D-Pa1(3) had only marginal effects on the antagonistic activities and receptor binding potencies of the D-Cit/D-Hci6 analogues, but it appeared to further improve the toxicity lowering effect of D-Cit/D-Hci6 substitution. Antagonists containing D-Pa1(3)3 and D-Cit/D-Hci6 residues, i.e. [Ac-D-Na1(2)1, D-Phe(4Cl)2, D-Pa1(3)3, D-Cit6, D-Ala10]LHRH (SB-75) and [Ac-D-Na1(2)1, D-Phe(4Cl)2, D-Pal(3)3, D-Hci6, D-Ala10]LHRH (SB-88), were completely free of the toxic effects, such as cyanosis and respiratory depression leading to death, which have been observed in rats with the D-Trp3, D-Arg6 antagonist and related antagonists. Replacement of the N-acetyl group with the hydrophilic carbamoyl group caused a slight decrease in antagonistic activities, particularly in vitro. Introduction of urethane type acyl group such as methoxycarbonyl (Moc) or t-butoxycarbonyl (Boc) led to analogues that showed LHRH-potentiating effect. The increase in potency induced by these analogues, e.g. [Moc-D-Na1(2)1, D-Phe(4Cl)2, D-Trp3, D-Cit6, D-Ala10]LHRH and [Boc-D-Phe1, D-Phe(4Cl)2, D-Pa1(3)3, D-Cit6, D-Ala10]LHRH, was 170-260{\%} and persisted for more than 2 h when studied in a superfused rat pituitary system.",
author = "S. Bajusz and Csernus, {V. J.} and T. Janaky and L. Bokser and M. Fekete and Schally, {Andrew V}",
year = "1988",
month = "12",
day = "1",
language = "English",
volume = "32",
pages = "425--435",
journal = "International Journal of Peptide and Protein Research",
issn = "0367-8377",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - New antagonists of LHRH. II. Inhibition and potentiation of LHRH by closely related analogues

AU - Bajusz, S.

AU - Csernus, V. J.

AU - Janaky, T.

AU - Bokser, L.

AU - Fekete, M.

AU - Schally, Andrew V

PY - 1988/12/1

Y1 - 1988/12/1

N2 - Modifications of the previously described LHRH antagonists, [Ac-D-Na1(2)1, D-Phe(4Cl)2, D-Trp3, D-Cit6, D-Ala10]LHRH and the corresponding D-Hci6 analogue, have been made to alter the hydrophobicity of the N-terminal acetyl-tripeptide portion. Substitution of D-Trp3 with the less hydrophobic D-Pa1(3) had only marginal effects on the antagonistic activities and receptor binding potencies of the D-Cit/D-Hci6 analogues, but it appeared to further improve the toxicity lowering effect of D-Cit/D-Hci6 substitution. Antagonists containing D-Pa1(3)3 and D-Cit/D-Hci6 residues, i.e. [Ac-D-Na1(2)1, D-Phe(4Cl)2, D-Pa1(3)3, D-Cit6, D-Ala10]LHRH (SB-75) and [Ac-D-Na1(2)1, D-Phe(4Cl)2, D-Pal(3)3, D-Hci6, D-Ala10]LHRH (SB-88), were completely free of the toxic effects, such as cyanosis and respiratory depression leading to death, which have been observed in rats with the D-Trp3, D-Arg6 antagonist and related antagonists. Replacement of the N-acetyl group with the hydrophilic carbamoyl group caused a slight decrease in antagonistic activities, particularly in vitro. Introduction of urethane type acyl group such as methoxycarbonyl (Moc) or t-butoxycarbonyl (Boc) led to analogues that showed LHRH-potentiating effect. The increase in potency induced by these analogues, e.g. [Moc-D-Na1(2)1, D-Phe(4Cl)2, D-Trp3, D-Cit6, D-Ala10]LHRH and [Boc-D-Phe1, D-Phe(4Cl)2, D-Pa1(3)3, D-Cit6, D-Ala10]LHRH, was 170-260% and persisted for more than 2 h when studied in a superfused rat pituitary system.

AB - Modifications of the previously described LHRH antagonists, [Ac-D-Na1(2)1, D-Phe(4Cl)2, D-Trp3, D-Cit6, D-Ala10]LHRH and the corresponding D-Hci6 analogue, have been made to alter the hydrophobicity of the N-terminal acetyl-tripeptide portion. Substitution of D-Trp3 with the less hydrophobic D-Pa1(3) had only marginal effects on the antagonistic activities and receptor binding potencies of the D-Cit/D-Hci6 analogues, but it appeared to further improve the toxicity lowering effect of D-Cit/D-Hci6 substitution. Antagonists containing D-Pa1(3)3 and D-Cit/D-Hci6 residues, i.e. [Ac-D-Na1(2)1, D-Phe(4Cl)2, D-Pa1(3)3, D-Cit6, D-Ala10]LHRH (SB-75) and [Ac-D-Na1(2)1, D-Phe(4Cl)2, D-Pal(3)3, D-Hci6, D-Ala10]LHRH (SB-88), were completely free of the toxic effects, such as cyanosis and respiratory depression leading to death, which have been observed in rats with the D-Trp3, D-Arg6 antagonist and related antagonists. Replacement of the N-acetyl group with the hydrophilic carbamoyl group caused a slight decrease in antagonistic activities, particularly in vitro. Introduction of urethane type acyl group such as methoxycarbonyl (Moc) or t-butoxycarbonyl (Boc) led to analogues that showed LHRH-potentiating effect. The increase in potency induced by these analogues, e.g. [Moc-D-Na1(2)1, D-Phe(4Cl)2, D-Trp3, D-Cit6, D-Ala10]LHRH and [Boc-D-Phe1, D-Phe(4Cl)2, D-Pa1(3)3, D-Cit6, D-Ala10]LHRH, was 170-260% and persisted for more than 2 h when studied in a superfused rat pituitary system.

UR - http://www.scopus.com/inward/record.url?scp=0024271361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024271361&partnerID=8YFLogxK

M3 - Article

C2 - 2469662

AN - SCOPUS:0024271361

VL - 32

SP - 425

EP - 435

JO - International Journal of Peptide and Protein Research

JF - International Journal of Peptide and Protein Research

SN - 0367-8377

IS - 6

ER -